ALPIX — Pixium Vision SA Share News
0.000.00%
- €0.52m
- €5.28m
- €1.96m
Brief: Pixium Vision: Drawdown Of New Tranche Under Financing With ESGO
Brief: Pixium Vision, Second Sight Medical Products Announce Business Combination
Brief: Pixium Vision Says Shareholder Structure Of Pixium Vision Following Capital Increase With Pre-Emptive Subscription Rights Of €7.3 Mln
Brief: Pixium Vision Receives Approval To Initiate European Primavera Pivotal Study Of Prima System
Brief: Pixium Vision Receives Approval To Initiate European PRIMAvera Pivotal Study Of Prima System
Brief: Pixium Vision Reports End-September Cash Flow Of EUR 13.3 Million
Brief: Pixium Vision H1 Net Loss Narrows To 3.8 Million Euros
Brief: Pixium Vision Announces Final Share Capital Breakdown
Brief: Pixium Raises EUR 7.3 Mln Through New Share Issue At EUR 0.5/Shr
Brief: Pixium Vision To Participate In French Healthcare Program By Business France And BPI France
Brief: Pixium Vision Cash Position As Of March 31 Down At 4.8 Million Euros
Brief: Pixium Vision: Positive Follow-Up Data From French Trial Of Prima System
Brief: Pixium Vision Says Decided To Postpone Continuing Feasibility Studies In France And US
Brief: Pixium Vision: Successful Activation Of Prima System In First U.S. Patient
Brief: Pixium Vision To Issue 1.25 Million New Tranche From ESGO Financing Agreement
Brief: Pixium Vision's Shares Will Be Transferred To Euronext Growth Paris On Feb 18
Brief: Pixium Vision Reports FY Revenue Up At 1.8 Million Euros
Brief: Pixium Vision Announces Successful Implantation Of Prima System
Brief: Pixium Vision: Successful Implantation Of First Patient In US With Prima System